US Compounding Inc recalls Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes, Hospital/Office Use Only. US Compounding 1270
US Compounding Inc recalls Neostigmine Methylsulfate injections with missing labels. This could lead to incorrect dosing. Contact for details.
Lower-risk recall
Labelling: Missing label.
Contact the company & request your remedy
What happened, in plain English
US Compounding Inc is recalling Neostigmine Methylsulfate injections due to missing labels. This could cause incorrect dosing if used without proper labeling. Read more at govinfonow.com/recall/36650-us-compounding-inc-neostigmine-injections-missing-label-recall.
Source Summary by GovInfoNow · govinfonow.com/recall/36650-us-compounding-inc-neostigmine-injections-missing-label-recall · Updated October 4, 2026 · FDA enforcement record: FDA #D-0175-2021
Cite this page
“US Compounding Inc: Neostigmine Injections Missing Label - Recall.” GovInfoNow, updated October 4, 2026. https://govinfonow.com/recall/36650-us-compounding-inc-neostigmine-injections-missing-label-recall. Based on FDA recall #D-0175-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0175-2021%22&limit=1).
Why it’s dangerous
Missing labels could lead to incorrect dosing of the medication. This is a labeling issue, not a safety hazard in normal use.
Who’s affected
Healthcare professionals and patients using these injections for medical treatment. Those with the specific lot number are most at risk.
How to tell if you have this one
Check for the lot number 20202109@3 with a batch date of 3/20/2021. The product is labeled as Neostigmine Methylsulfate PF Inj. 5 mg/5 mL, 5 mL Single Use Syringes.
- Brand
US Compounding Inc- Category
Drug
What to do — step by step
Check Label
Verify if the label is missing or incomplete on the injection syringes.
Questions people ask
Why is this product being recalled?
The product has a missing label, which could lead to incorrect dosing.
What should I do if I have this product?
Check if the label is missing or incomplete. Contact US Compounding Inc for further instructions.
Is there a risk of serious injury?
The recall is for labeling issues, not a safety hazard in normal use.
Contact US Compounding Inc
We’ve drafted a message you can send US Compounding Inc to request your refund or repair — edit it as you like.
Subject: Recall D-0175-2021 — US Compounding Inc US Compounding Inc Hello, I own a US Compounding Inc that is covered by recall D-0175-2021 from US Compounding Inc. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Similar recalls
Keep exploring
From people who’ve dealt with this
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0175-2021 (November 25, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0175-2021 to see it in context.
- Plain-language summary written by qwen3:4b on October 4, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.